NEW YORK: Brunswick once again topped the Mergermarket League Tables as the top PR adviser for M&A deals in terms of value. During a year with a 27% decline in global M&A activity, Brunswick worked 106 deals valued at $321.7 billion. However, that represents a 36% decline from the number of deals the agency worked in 2008, according to last year's Mergermarket's figures.
Brunswick's involvement in two Q4 deals, Rio Tinto/BHP Billiton and Kraft/Cadbury, boosted its work toward the end of the year. The agency's other major deals of 2009 were advising Pfizer on its purchase of Wyeth and Roche on its acquisition of Genentech.
The other top three firms in terms of value were WPP's London-based Finsbury Group with $195 billion and Publicis Groupe's Kekst & Co. with $141.5 billion.
In terms of volume, FD advised on the largest number of deals, 148. Brunswick followed and Finsbury Group was third with 89 deals.
M&A activity was highest in Q4 during 2009, with a higher number of both global and North American deals than any previous quarter in 2009.
The top North American deals for 2009 were Pfizer/Wyeth, valued at $63.3 billion; the General Motors restructuring, "Vehicle Acquisition Holdings/Motors Liquidation," valued at $48.2 billion with Kekst & Co. and Sloane & Co.; and Roche/Genentech, valued at $44.3 billion.
Mergermarket expects both M&A and IPO activity to increase in 2010.